Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach sold 5,735 shares of the firm’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $2.28, for a total transaction of $13,075.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Paul David Bach also recently made the following trade(s):
- On Tuesday, June 5th, Paul David Bach sold 10,131 shares of Genesis Healthcare stock. The stock was sold at an average price of $2.19, for a total transaction of $22,186.89.
Shares of Genesis Healthcare traded up $0.25, hitting $2.65, during midday trading on Thursday, MarketBeat.com reports. The company’s stock had a trading volume of 1,813,857 shares, compared to its average volume of 714,116. Genesis Healthcare Inc has a 12-month low of $0.60 and a 12-month high of $2.70. The company has a market cap of $366.72 million, a P/E ratio of -1.27 and a beta of 1.00. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of -2.80.
Genesis Healthcare (NYSE:GEN) last released its quarterly earnings data on Thursday, May 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.34). The company had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same period in the prior year, the firm posted ($0.55) EPS. analysts expect that Genesis Healthcare Inc will post -1.32 earnings per share for the current year.
A number of institutional investors have recently added to or reduced their stakes in GEN. Schwab Charles Investment Management Inc. acquired a new stake in Genesis Healthcare during the first quarter worth about $153,000. BSW Wealth Partners increased its position in Genesis Healthcare by 74.2% during the first quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock worth $174,000 after purchasing an additional 49,000 shares during the last quarter. Millennium Management LLC acquired a new stake in Genesis Healthcare during the fourth quarter worth about $184,000. Virtu Financial LLC acquired a new stake in Genesis Healthcare during the fourth quarter worth about $203,000. Finally, California Public Employees Retirement System increased its position in Genesis Healthcare by 23.3% during the first quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock worth $468,000 after purchasing an additional 58,610 shares during the last quarter. Hedge funds and other institutional investors own 18.70% of the company’s stock.
Several equities analysts have recently weighed in on the stock. Stephens reissued a “hold” rating and issued a $2.00 price target on shares of Genesis Healthcare in a research note on Monday, March 19th. Stifel Nicolaus set a $2.00 price target on shares of Genesis Healthcare and gave the stock a “hold” rating in a research note on Tuesday, April 24th. Finally, ValuEngine downgraded shares of Genesis Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Genesis Healthcare presently has an average rating of “Hold” and a consensus target price of $2.00.
About Genesis Healthcare
Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.